These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 19129465
21. Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol. Urban N, Neuser S, Hentschel A, Köhling S, Rademann J, Schaefer M. Br J Pharmacol; 2017 Nov; 174(22):4099-4122. PubMed ID: 28800680 [Abstract] [Full Text] [Related]
23. Sustained activation of N-methyl-D-aspartate receptors in podoctyes leads to oxidative stress, mobilization of transient receptor potential canonical 6 channels, nuclear factor of activated T cells activation, and apoptotic cell death. Kim EY, Anderson M, Dryer SE. Mol Pharmacol; 2012 Oct; 82(4):728-37. PubMed ID: 22828802 [Abstract] [Full Text] [Related]
24. TRPC6 - a new podocyte gene involved in focal segmental glomerulosclerosis. Kriz W. Trends Mol Med; 2005 Dec; 11(12):527-30. PubMed ID: 16290061 [Abstract] [Full Text] [Related]
25. Nuclear factor of activated T cells mediates RhoA-induced fibronectin upregulation in glomerular podocytes. Zhu L, Qi XY, Aoudjit L, Mouawad F, Baldwin C, Nattel S, Takano T. Am J Physiol Renal Physiol; 2013 Apr 01; 304(7):F849-62. PubMed ID: 23389455 [Abstract] [Full Text] [Related]
26. Contribution of Coiled-Coil Assembly to Ca2+/Calmodulin-Dependent Inactivation of TRPC6 Channel and its Impacts on FSGS-Associated Phenotypes. Polat OK, Uno M, Maruyama T, Tran HN, Imamura K, Wong CF, Sakaguchi R, Ariyoshi M, Itsuki K, Ichikawa J, Morii T, Shirakawa M, Inoue R, Asanuma K, Reiser J, Tochio H, Mori Y, Mori MX. J Am Soc Nephrol; 2019 Sep 01; 30(9):1587-1603. PubMed ID: 31266820 [Abstract] [Full Text] [Related]
27. MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes. Wu J, Zheng C, Wang X, Yun S, Zhao Y, Liu L, Lu Y, Ye Y, Zhu X, Zhang C, Shi S, Liu Z. J Clin Invest; 2015 Nov 02; 125(11):4091-106. PubMed ID: 26436650 [Abstract] [Full Text] [Related]
28. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. Kuwahara K, Wang Y, McAnally J, Richardson JA, Bassel-Duby R, Hill JA, Olson EN. J Clin Invest; 2006 Dec 02; 116(12):3114-26. PubMed ID: 17099778 [Abstract] [Full Text] [Related]
29. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury. Yu M, Hu J, Ju T, Wang R, Wang M, Gao C, Xia Z. Cell Mol Biol (Noisy-le-grand); 2024 May 27; 70(5):284-288. PubMed ID: 38814201 [Abstract] [Full Text] [Related]
30. A novel TRPC6 mutation that causes childhood FSGS. Heeringa SF, Möller CC, Du J, Yue L, Hinkes B, Chernin G, Vlangos CN, Hoyer PF, Reiser J, Hildebrandt F. PLoS One; 2009 Nov 10; 4(11):e7771. PubMed ID: 19936226 [Abstract] [Full Text] [Related]
31. Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes. Kim EY, Alvarez-Baron CP, Dryer SE. Mol Pharmacol; 2009 Mar 10; 75(3):466-77. PubMed ID: 19052171 [Abstract] [Full Text] [Related]
32. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease. Sonneveld R, Ferrè S, Hoenderop JG, Dijkman HB, Berden JH, Bindels RJ, Wetzels JF, van der Vlag J, Nijenhuis T. Am J Pathol; 2013 Apr 10; 182(4):1196-204. PubMed ID: 23385000 [Abstract] [Full Text] [Related]
33. WNK1 promotes renal tumor progression by activating TRPC6-NFAT pathway. Kim JH, Hwang KH, Eom M, Kim M, Park EY, Jeong Y, Park KS, Cha SK. FASEB J; 2019 Jul 10; 33(7):8588-8599. PubMed ID: 31022353 [Abstract] [Full Text] [Related]
34. Protein kinase C-dependent phosphorylation of transient receptor potential canonical 6 (TRPC6) on serine 448 causes channel inhibition. Bousquet SM, Monet M, Boulay G. J Biol Chem; 2010 Dec 24; 285(52):40534-43. PubMed ID: 20961851 [Abstract] [Full Text] [Related]
35. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression. Ma R, Liu L, Jiang W, Yu Y, Song H. Int J Clin Exp Pathol; 2015 Dec 24; 8(11):14063-74. PubMed ID: 26823720 [Abstract] [Full Text] [Related]
36. TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype. Gigante M, Caridi G, Montemurno E, Soccio M, d'Apolito M, Cerullo G, Aucella F, Schirinzi A, Emma F, Massella L, Messina G, De Palo T, Ranieri E, Ghiggeri GM, Gesualdo L. Clin J Am Soc Nephrol; 2011 Jul 24; 6(7):1626-34. PubMed ID: 21734084 [Abstract] [Full Text] [Related]
37. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Reiser J, Polu KR, Möller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR. Nat Genet; 2005 Jul 24; 37(7):739-44. PubMed ID: 15924139 [Abstract] [Full Text] [Related]
38. Structural mechanism of human TRPC3 and TRPC6 channel regulation by their intracellular calcium-binding sites. Guo W, Tang Q, Wei M, Kang Y, Wu JX, Chen L. Neuron; 2022 Mar 16; 110(6):1023-1035.e5. PubMed ID: 35051376 [Abstract] [Full Text] [Related]
39. TRPC channel modulation in podocytes-inching toward novel treatments for glomerular disease. El Hindi S, Reiser J. Pediatr Nephrol; 2011 Jul 16; 26(7):1057-64. PubMed ID: 21161284 [Abstract] [Full Text] [Related]
40. NFAT activation by membrane potential follows a calcium pathway distinct from other activity-related transcription factors in skeletal muscle cells. Valdés JA, Gaggero E, Hidalgo J, Leal N, Jaimovich E, Carrasco MA. Am J Physiol Cell Physiol; 2008 Mar 16; 294(3):C715-25. PubMed ID: 18184878 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]